Stocks waiting for the news

WATCH OUT

Wockhardt has informed the Bombay Stock Exchange that Wockhardt UK Ltd, the British arm of the Indian pharmaceutical major, on Thursday announced the sale of its Luton plant near London to the UK-based Bristol Laboratories.

Products of Wallis manufactured earlier at Luton, have been shifted to CP Pharmaceuticals' plant at Wrexham in Wales and to Wockhardt's plants in India.

"We are upgrading the Wales plant as Wockhardt's largest overseas manufacturing base at an investment of one million pound sterling," Wockhardt chairman Habil Khorakiwala said.

The upgraded Wales plant will become a manufacturing base for Wockhardt's German subsidiary esparma GmbH.